Issues in Emerging Health Technologies

Issues in Emerging Health Technologies is a series of concise bulletins describing drug and non-drug technologies that are not yet used (or widely diffused) in Canada; in most cases, Health Canada’s approval is anticipated in the next six to 18 months. Bulletins include a description of the emerging technology; patient indications; regulatory status; adverse effects; costs; anticipated diffusion rates; implementation issues; and a discussion of the reliability and quality of available evidence. While the bulletins analyze all available data, the evidence base is generally insufficient to permit a meta-analysis of individual trials or other statistical analyses. Each bulletin is peer reviewed by two or more external clinical experts.

While we are no longer printing hard copies of Issues in Emerging Health Technologies, electronic (pdf) versions may be downloaded.

Subscribe to receive e-mail notification of new issues of the publication.